Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.

Zhang X, Lin T, Bertasso A, Evans C, Dorr A, Kolis SJ, Salgo M, Patel I; T20-310/NV16056 Study Group.

J Clin Pharmacol. 2007 Apr;47(4):510-7.

PMID:
17389560
2.

Effect of R667, a novel emphysema agent, on the pharmacokinetics of midazolam in healthy men.

Brennan BJ, Brown AB, Kolis SJ, Rutman O, Gooden C, Davies BE.

J Clin Pharmacol. 2006 Feb;46(2):222-8.

PMID:
16432274
3.

Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS.

Chang D, Kolis SJ, Linderholm KH, Julian TF, Nachi R, Dzerk AM, Lin PP, Lee JW, Bansal SK.

J Pharm Biomed Anal. 2005 Jul 1;38(3):487-96.

PMID:
15925250
4.

Pharmacokinetics of enfuvirtide in pediatric human immunodeficiency virus 1-infected patients receiving combination therapy.

Bellibas SE, Siddique Z, Dorr A, Bertasso A, Sista P, Kolis SJ, Cotler S, Delora P; T20-310/NV16056 Study Group.

Pediatr Infect Dis J. 2004 Dec;23(12):1137-41.

PMID:
15626952
5.

Assessment of drug-drug interaction potential of enfuvirtide in human immunodeficiency virus type 1-infected patients.

Zhang X, Lalezari JP, Badley AD, Dorr A, Kolis SJ, Kinchelow T, Patel IH.

Clin Pharmacol Ther. 2004 Jun;75(6):558-68.

PMID:
15179410
6.

Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patients.

Lalezari JP, Patel IH, Zhang X, Dorr A, Hawker N, Siddique Z, Kolis SJ, Kinchelow T.

J Clin Virol. 2003 Oct;28(2):217-22.

PMID:
12957192
7.

Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.

Kolis SJ, Postma EJ, Williams TH, Sasso GJ.

Drug Metab Dispos. 1986 Jul-Aug;14(4):465-70.

PMID:
2873994
8.

Metabolites of an antipsychotic chiral pyrroloisoquinoline and their effect on prolactin secretion in the rat.

Kolis SJ, Williams TH, Mowles TF, Burghardt B, Toome V, Schwartz MA.

J Pharmacol Exp Ther. 1983 Dec;227(3):652-7.

PMID:
6140308
9.

Metabolism of an anxiolytic imidazobenzodiazepine by the dog.

Kolis SJ, Postma EJ, Williams TH, Sasso GJ, Schwartz MA.

Drug Metab Dispos. 1983 Jul-Aug;11(4):324-8.

PMID:
6137338
10.

Biotransformation of [14C]midazolam in the rat in vitro and in vivo.

Woo GK, Williams TH, Kolis SJ, Warinsky D, Sasso GJ, Schwartz MA.

Xenobiotica. 1981 Jun;11(6):373-84.

PMID:
7293228
11.

The metabolism of 14C-methoxsalen by the dog.

Kolis SJ, Williams TH, Postma EJ, Sasso GJ, Confalone PN, Schwartz MA.

Drug Metab Dispos. 1979 Jul-Aug;7(4):220-5.

PMID:
39724
12.

Biotransformation of prochiral 2-phenyl-1,3-di(4-pyridyl)-2-propanol to a chiral N-oxide metabolite.

Schwartz MA, Williams TH, Kolis SJ, Postma E, Sasso GJ.

Drug Metab Dispos. 1978 Nov-Dec;6(6):647-53.

PMID:
33027
13.

A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.

Cohen MR, Hinsch E, Vergona R, Ryan J, Kolis SJ, Schwartz MA.

J Pharmacol Exp Ther. 1976 Jun;197(3):697-702.

PMID:
932999
14.

Identification of the urinary metabolites of 14C-bumetanide in the rat and their excretion by rats and dogs.

Kolis SJ, Williams TH, Schwartz MA.

Drug Metab Dispos. 1976 Mar-Apr;4(2):169-76.

PMID:
5262
15.

The in vitro metabolism of 2-hydroxynicotinic acid in human erythrocytes and platelets.

Kolis SJ, Schwartz MA, Gaut ZN, Ashley CJ.

Drug Metab Dispos. 1974 Sep-Oct;2(5):424-8. No abstract available.

PMID:
4156304
16.

Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat, and mouse.

Schwartz MA, Postma E, Kolis SJ, Leon AS.

J Pharm Sci. 1973 Nov;62(11):1776-9. No abstract available.

PMID:
4758074
17.

Biotransformation of 2-hydroxynicotinic acid: N-riboside formation in vivo.

Schwartz MA, Kolis SJ, Williams TH, Gabriel TF, Toome V.

Drug Metab Dispos. 1973 May-Jun;1(3):557-64. No abstract available.

PMID:
4149449
18.

Oxidation of an amino carbinol by an NAD+-dependent microsomal dehydrogenase.

Schwartz MA, Kolis SJ.

Drug Metab Dispos. 1973 Jan-Feb;1(1):322-31. No abstract available.

PMID:
4149400
19.

Pathways of medazepam metabolism in the dog and rat.

Schwartz MA, Kolis SJ.

J Pharmacol Exp Ther. 1972 Jan;180(1):180-8. No abstract available.

PMID:
5010413
20.

Metabolism of demoxepam, a chlordiazepoxide metabolite, in the dog.

Schwartz MA, Postma E, Kolis SJ.

J Pharm Sci. 1971 Mar;60(3):438-44. No abstract available.

PMID:
5572124

Supplemental Content

Loading ...
Support Center